Pacific Health Summit

Last updated
Pacific Health Summit
Formation2005
Type conference
Headquarters1414 NE 42nd Street, Suite 300 Seattle, WA 98105
Location
Website pacifichealthsummit.org and nbr.org

The goal of the Pacific Health Summit is to connect science, industry, and policy for a healthier world. Traditionally, the main work of the Summit has been an annual meeting, where top decision makers convene to discuss how to realize the dream of a healthier future through the effective utilization of scientific advances, combined with industrial innovation and appropriate policies. In autumn of 2012 on the heels of its eight major conference, the Summit shifted its focus from an annual meeting to more targeted work that builds on the past themes and concrete outcomes. As it has since 2005, the Summit will continue to provide a year-round forum for world leaders to grapple with problems and solutions, share best practices, and forge effective collaborations.

Contents

History

The first Pacific Health Summit was held in Seattle, Washington, in 2005 with foundational support from the Bill & Melinda Gates Foundation and the Russell Family Foundation. [1] It was the co-creation of 2001 Nobel Prize in physiology or medicine winner Leland H. Hartwell, businessman and philanthropist George F. Russell Jr., Co-chair of the Bill & Melinda Gates Foundation William H. Gates Sr., and Founding Director of the National Bureau of Asian Research’s Center for Health and Aging Michael Birt. [2] NBR has been the Secretariat of the Summit since the inaugural 2005 conference.

Birt, founding executive director of the Summit, stepped down from his role as NBR’s Center for Health and Aging director in 2009, and from his role as executive director in 2012, handing the mantle to Claire Topal, the Summit's managing director, who ran the Summit and managed the team from 2009-2012. She now serves as senior advisor for international health to NBR. Nualchan Sakchalathorn, the Summit’s project director, served on the Summit team from 2007-2012.

Building on Bill Gates Sr.'s strong personal support, in 2007 Tachi Yamada, then president of Global Health at the Bill & Melinda Gates Foundation, took on a decisive leadership role and formally established the Foundation as the Summit's third co-presenting organization.

In 2008, the Wellcome Trust joined the Summit as the fourth official co-presenting organization, and trust director, Sir Mark Walport, joined the executive committee. Both Sir William Castell, chairman of the Wellcome Trust, who has participated in the Summit since its first year, and Sir Mark provided crucial leadership as the Summit began its rotation in London for the annual meeting.

Peter Neupert, then corporate vice president for health solutions strategy for Microsoft, and Craig Mundie, chief research and strategy officer of Microsoft, consistently provided a private sector perspective to the Summit's strategic discussions. Additionally, GE Healthcare, through Bill Castell in 2005, has always provided critical advice and perspective, as well as the critical founding sponsorship for the annual meeting.

Out of this initial foundation of leadership, the Summit grew into one of the world's premier global health gatherings every year. In 2012, eight years after the inaugural meeting, which was never designed to take place in perpetuity, global health is in an exciting new place. The Summit’s interactive format has proliferated, and decision-makers across all sectors and geographies are collaborating on all the critical global health issues the Summit sought to address: health technology, pandemic flu, MDR-TB, vaccines, malnutrition, maternal and newborn health, and many more. While the Summit is proud of eight years of transformational conversations, countless new friendships, and exciting partnerships, there is still much work to do – and so much momentum on which to build. NBR is looking forward and excited to build on the Summit’s legacy in the years to come.

Outcomes

The Summit has been a catalyst for partnerships, and the setting of several global health announcements. [3] In 2007, during a speech [4] at the Summit, Margaret Chan, Director-General of the World Health Organization, publicized “a new initiative to establish a world stockpile of vaccines to prepare for the threat of pandemic influenza.” [5] At the Summit in 2009, Sanofi bolstered that stockpile with 100 million donated doses of flu vaccine. [6] Other partnerships furthered by, or formed at, the Summit have helped to lead to the establishment of the MSD Wellcome Trust Hilleman Laboratories, [7] the Access to Nutrition Index, the Critical Path to TB Drug Regimens, [8] and a cervical cancer vaccination deal between Merck & Co. and Qiagen. [9] Additionally, the denial of a US visa for 2009 Summit participant Paul Thorn of the Tuberculosis Survival Project, due to his HIV positive status, became the impetus behind the repeal of a US travel restriction law on individuals carrying the HIV/AIDs virus. [10]

Publications, Videos, and Photos

The Summit Secretariat, the Center for Health and Aging at The National Bureau of Asian Research, publishes reports, videos, and photos of Summit sessions and workshops. The organization also produces expert interviews and thought pieces with Summit participants on past themes and current global health topics. Prior to each Summit, the Center publishes a ‘Calls for Collaboration’ report. The publication contains submissions from organizations inviting Summit participants to partner and collaborate around specific areas of need.

Past Themes

Related Research Articles

<span class="mw-page-title-main">Bill & Melinda Gates Foundation</span> Private foundation founded by Bill and Melinda Gates

The Bill & Melinda Gates Foundation (BMGF), a merging of the William H. Gates Foundation and the Gates Learning Foundation, is an American private foundation founded by Bill Gates and Melinda French Gates. Based in Seattle, Washington, it was launched in 2000 and is reported as of 2020 to be the second largest charitable foundation in the world, holding $49.8 billion in assets. On his 43rd birthday, Bill Gates gave the foundation $1 billion. The primary stated goals of the foundation are to enhance healthcare and reduce extreme poverty across the world, and to expand educational opportunities and access to information technology in the U.S. Key individuals of the foundation include Bill Gates, Melinda French Gates, Warren Buffett, chief executive officer Mark Suzman, and Michael Larson.

<span class="mw-page-title-main">International AIDS Vaccine Initiative</span> Not-for-profit, public-private partnership

The International AIDS Vaccine Initiative (IAVI) is a global not-for-profit, public-private partnership working to accelerate the development of vaccines to prevent HIV infection and AIDS. IAVI researches and develops vaccine candidates, conducts policy analyses, serves as an advocate for the HIV prevention field and engages communities in the trial process and AIDS vaccine education. The organization takes a comprehensive approach to HIV and AIDS that supports existing HIV prevention and treatment programs while emphasizing the need for new AIDS prevention tools. It also works to ensure that future vaccines will be accessible to all who need them.

Since October 2018, the Center for Global Infectious Disease Research has been part of the Seattle Children's Research Institute. At the time of the merger, CID Research had 166 scientists. Its mission was to eliminate the world's most devastating infectious diseases through leadership in scientific discovery. The organization's research labs were in the South Lake Union area of Seattle, WA. The institute's research focused on four areas of infectious disease: HIV/AIDS, malaria, tuberculosis (TB), and Emerging & Neglected Diseases (END) like African sleeping sickness, leishmaniasis, Chagas disease, and toxoplasmosis. CID Research was engaged in early stages of the scientific pipeline including bench science and malaria clinical trials and has expertise in immunology, vaccinology, and drug discovery.

The European and Developing Countries Clinical Trials Partnership (EDCTP) is a partnership between the European Union (EU), Norway, Switzerland and developing countries and other donors, as well as the pharmaceutical industry, to enable clinical trials and the development of new medicines and vaccines against HIV/AIDS, tuberculosis, and malaria. The need for global action against these diseases in order to promote poverty reduction has been recognised by the United Nations, the G8, and the African Union, and the program envisioned the provision of €600 million for the period 2003–2007 in order to translate medical research results into clinical applications relevant to the needs of developing countries.

The University of Washington Department of Global Health is a department jointly run by the schools of Medicine and Public Health at the University of Washington in Seattle, Washington. Its aim is to provide a multidisciplinary venue to address issues of global health at the university.

<span class="mw-page-title-main">PATH (global health organization)</span> Global health nonprofit

PATH is an international, nonprofit global health organization based in Seattle, with 1,600 employees in more than 70 countries around the world. Its president and CEO is Nikolaj Gilbert, who is also the Managing Director and CEO of Foundations for Appropriate Technologies in Health (FATH), PATH's Swiss subsidiary. PATH focuses on six platforms—vaccines, drugs, diagnostics, devices, system, and service innovations—to develop innovations and implement solutions that save lives and improve health.

The Grand Challenges in Global Health (GCGH) is a research initiative launched by the Bill & Melinda Gates Foundation in search of solutions to health problems in the developing world. Fifteen challenges are categorized in groups among seven stated goals plus an eighth group for family health. The disciplines involved include immunology, microbiology, genetics, molecular biology and cellular biology, entomology, agricultural sciences, clinical sciences, epidemiology, population and behavioral sciences, ecology, and evolutionary biology.

The National Bureau of Asian Research (NBR) is an American nonprofit, research institution based in Seattle, Washington, with a branch office in Washington, D.C.

The Collaboration for AIDS Vaccine Discovery (CAVD) is an international network of scientists, research organizations, and promoters of HIV vaccine research.

<span class="mw-page-title-main">Trevor Neilson</span>

Trevor Neilson is an American businessperson, investor, entrepreneur and philanthropist. He is the Co-founder, Chairman and CEO of WasteFuel, a company that produces renewable fuels using proven technologies to address the climate emergency and revolutionize mobility.

Barry R. Bloom is Harvard University Distinguished Service Professor and Joan L. and Julius H. Jacobson Professor of Public Health in the Department of Immunology and Infectious Diseases and Department of Global Health and Population in the Harvard T.H. Chan School of Public Health in Boston, where he served as dean of the faculty from 1998 through December 31, 2008.

This page is a timeline of global health, including major conferences, interventions, cures, and crises.

The Coalition for Epidemic Preparedness Innovations (CEPI) is a foundation that takes donations from public, private, philanthropic, and civil society organisations, to finance independent research projects to develop vaccines against emerging infectious diseases (EID).

<span class="mw-page-title-main">Helen Rees</span>

Helen Rees OBE GCOB is a medical researcher and the founder and Executive Director of the Wits Reproductive Health and HIV Institute of the University of Witwatersrand. She has led many HIV prevention and sexual and reproductive health studies and advised on vaccination strategies to help prevent various medical conditions.

Margaret A. Liu is a physician and researcher studying gene expression, immune responses, and vaccines. From 2015-2017, Liu served as President of the International Society of Vaccines. She is currently a professor of microbiology and immunology at the University of California, San Francisco (UCSF) and a foreign adjunct professor at the Karolinska Institute in Stockholm, Sweden. Since June 7, 2017, she has been a director of Ipsen S.A. in France.

Melita Alison Gordon is a gastroenterologist who works on invasive gut pathogens and tropical gastrointestinal disease. She leads the Malawi Liverpool Wellcome Trust Salmonella and Enterics Group. Gordon was awarded the British Society of Gastroenterology Sir Francis Avery Jones Research Medal in 2011.

Planning and preparing for pandemics has happened in countries and international organizations. The World Health Organization writes recommendations and guidelines, though there is no sustained mechanism to review countries' preparedness for epidemics and their rapid response abilities. National action depends on national governments. In 2005–2006, before the 2009 swine flu pandemic and during the decade following it, the governments in the United States, France, UK, and others managed strategic health equipment stocks, but they often reduced stocks after the 2009 pandemic in order to reduce costs.

Marta Tufet Bayona is a British and Spanish biologist and public health resource coordinator with a specialty in malaria. She is Executive Director of the UK Collaborative on Development Research.

Gavin Mark Yamey is a British-American physician and global health researcher. He is the director of the Center for Policy Impact in Global Health at Duke University and a professor of the practice of global health and public policy.

Ann Marie Kimball is an American physician. She is known for being the pioneer of electronic disease surveillance for infectious disease outbreaks and pandemics. She is currently a Professor Emerita in the Department of Epidemiology at the University of Washington, a Consulting Fellow at the Chatham House Royal Institute of Foreign Affairs, and was a Strategic Consultant in Global Health at the Rockefeller Foundation. Kimball served as a technical and strategic lead for the Bill and Melinda Gates Foundation infectious disease surveillance strategy formation.

References

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.